Docs struggle with making MCI diagnoses, 2022 Alzheimer’s report finds
By
Alicia Lasek
Mar 23, 2022
Less than half of primary care physicians surveyed report being comfortable diagnosing mild cognitive impairment that’s due to Alzheimer’s disease. Fully 90% told researchers that it is “hard...
Clinical briefs for Tuesday, April 6
By
Alicia Lasek
Apr 06, 2021
COVID outbreak among vaccinated assisted living residents under investigation … FDA rejects bid to approve Nuplazid for treatment of dementia-related psychosis … J&J betting $780M on long-acting antiviral...
Popular TV series may help reduce stigma around Alzheimer’s
By
John Roszkowski
Sep 02, 2022
The narrative and dramatization of Alzheimer’s disease in the popular TV series “This is Us” may help reduce the stigma around dementia and promote family discussions about plans for aging, new...
PPIs do not raise dementia risk, review finds
By
Alicia Lasek
Jan 06, 2020
There is no link between a common class of acid reflux medications and increased dementia risk, according to a new analysis.
Asian Americans largely steer clear of brain MRIs for research, study shows
By
Kristen Fischer
Feb 12, 2024
Asian Americans are less likely than white people to take part in medical research that involves magnetic resonance imaging (MRI) scans. Dealing with this hesitancy could improve research, according to...
MA enrollees with dementia report poor quality of care: study
By
Alicia Lasek (f3)
May 09, 2022
Medicare Advantage plans will be more incentivized to address gaps in care if consumer care assessments include more input from enrollees with dementia, investigators say.
One in three Alzheimer, dementia cases tied to modifiable risk factors
May 11, 2022
Midlife obesity, physical inactivity and low education are three prominent modifiable risk factors tied to dementia, researchers say.
Unique form of dementia is common, may require alternate therapies, experts say
By
Alicia Lasek (f3)
Jun 15, 2022
Brain changes linked to a recently identified form of dementia may be present in fully 40% of older adults, neurologists say.
FDA advisors to weigh use of Rexulti for Alzheimer’s agitation
By
Alicia Lasek
Apr 10, 2023
Expert advisors are set to determine whether Rexulti (brexpiprazole) is effective and safe for this new application, the FDA announced Monday.
Mid-life racial discrimination in Black Americans tied to Alzheimer’s later on, study finds
By
Kristen Fischer
Apr 12, 2024
Racial discrimination during midlife is linked to Alzheimer’s disease, a new study finds.